Egg ovotransferrin-derived ACE inhibitory peptide IRW increases ACE2 but decreases proinflammatory genes expression in mesenteric artery of spontaneously hypertensive rats

Molecular Nutrition and Food Research

Volumn 59, Issue 9, 2015, Pages 1735-1744

  Majumder, Kaustav ^a   Liang, Guanxiang ^a   Chen, Yanhong ^a   Guan, Leluo ^a   Davidge, Sandra T ^a,b   Wu, Jianping ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

ACE 2; Bioactive peptides; Hypertension; RNAseq; SHR

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIZZY RELATED PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 3; OVOTRANSFERRIN; PEPTIDE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL; BLOOD PRESSURE; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC DATABASE; GENETICS; MESENTERIC ARTERY; METABOLISM; RAT; SEQUENCE ANALYSIS; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CDH1 PROTEINS; CONALBUMIN; DATABASES, GENETIC; GENE EXPRESSION REGULATION; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON REGULATORY FACTORS; MESENTERIC ARTERIES; P-GLYCOPROTEINS; PEPTIDES; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, INBRED SHR; SEQUENCE ANALYSIS, RNA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84942826619     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500050     Document Type: Article

References (63)

1. WHO (World Health Organization). A Global Brief on Hypertension, silent killer, global public health crisis- 2013. Available from: URL: http://apps.who.int/iris/bitstream/10665/79059/1/WHO_DCO_WHD_2013.2eng.pdf?ua=1.
2. Hall, J. E., Granger, J. P., do Carmo, J. M., da Silva, A. A. et al., Hypertension: physiology and pathophysiology. Compr. Physiol. 2012, 2, 2393-2442.
3. Chockalingam, A., World hypertension day and global awareness. Can. J. Cardiol. 2008, 24, 441-444.
4. Gavras, H., Gavras, I., Angiotensin converting enzyme inhibitors. Properties and side effects. Hypertension 1988, 11, II37-II41.
5. Viera, A. J., Neutze, D. M., Diagnosis of secondary hypertension: an age-based approach. Am. Fam. Physician 2010, 82, 1471-1478.
6. Cicero, A. F. G., Gerocarni, B., Laghi, L., Borghi, C., Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials. J. Hum. Hypertens. 2011, 25, 425-436.
7. Ehlers, P. I., Nurmi, L., Turpeinen, A. M., Korpela, R., Vapaatalo, H., Casein-derived tripeptide Ile-Pro-Pro improves angiotensin-(1-7)- and bradykinin-induced rat mesenteric artery relaxation. Life Sci. 2011, 88, 206-211.
8. Turpeinen, A. M., Jarvenpaa, S., Kautiainen, H., Korpela, R., Vapaatalo, H., Antihypertensive effects of bioactive tripeptides-a random effects meta-analysis. Ann. Med. 2013, 45, 51-56.
9. Boelsma, E., Kloek, J., IPP-rich milk protein hydrolysate lowers blood pressure in subjects with stage 1 hypertension, a randomized controlled trial. Nutr. J. 2010, 9, 52-58.
10. Yamaguchi, N., Kawaguchi, K., Yamamoto, N., Study of the mechanism of antihypertensive peptides VPP and IPP in spontaneously hypertensive rats by DNA microarray analysis. Eur. J. Pharmacol. 2009, 620, 71-77.
11. Geleijnse, J. M., Engberink, M. F., Lactopeptides and human blood pressure. Curr. Opin. Lipidol. 2010, 21, 58-63.
12. Agyei, D., Danquah, M. K., Rethinking food-derived bioactive peptides for antimicrobial and immunomodulatory activities. Trends Food Sci. Technol. 2012, 23, 62-69.
13. Wu, J., Majumder, K., Gibbons, K., Bioactive Proteins and Peptides from Egg Proteins, Wiley-Blackwell, Singapore 2010, pp. 247-263.
14. Miguel, M., Aleixandre, A., Anti-hypertensive peptides derived from egg proteins. J. Nutr. 2006, 136, 1457-1460.
15. Majumder, K., Wu, J., A new approach for identification of novel antihypertensive peptides from egg proteins by QSAR and bioinformatics. Food Res. Int. 2010, 43, 1371-1378.
16. Huang, W., Shen, S., Nimalaratne, C., Li, S. et al., Effects of addition of egg ovotransferrin-derived peptides on the oxygen radical absorbance capacity of different teas. Food Chem. 2012, 135, 1600-1607.
17. Majumder, K., Chakrabarti, S., Davidge, S. T., Wu, J. Structure and activity study of egg protein ovotransferrin derived peptides (IRW and IQW) on endothelial inflammatory response and oxidative stress. J. Agric. Food Chem. 2013, 61, 2120-2129.
18. Majumder, K., Chakrabarti, S., Morton, J. S., Panahi, S. et al., Egg-derived tri-peptide IRW exerts antihypertensive effects in spontaneously hypertensive rats. PLoS One 2013, 8, e82829.
19. Nakamura, T., Hirota, T., Mizushima, K., Ohki, K. et al., Milk-derived peptides, Val-Pro-Pro and Ile-Pro-Pro, attenuate atherosclerosis development in apolipoprotein e-deficient mice: a preliminary study. J. Med. Food 2013, 16, 396-403.
20. Aihara, K., Osaka, M., Yoshida, M., Oral administration of the milk casein-derived tripeptide Val-Pro-Pro attenuates high-fat diet-induced adipose tissue inflammation in mice. Br. J. Nutr. 2014, 112, 513-519.
21. Fernandez-Musoles, R., Castello-Ruiz, M., Arce, C., Manzanares, P. et al., Antihypertensive mechanism of lactoferrin-derived peptides: angiotensin receptor blocking effect. J. Agric. Food Chem. 2014, 62, 173-181.
22. Yamaguchi, N., Kawaguchi, K., Yamamoto, N., Study of the mechanism of antihypertensive peptides VPP and IPP in spontaneously hypertensive rats by DNA microarray analysis. Eur. J. Pharmacol. 2009, 620, 71-77.
23. Yu, Z., Yin, Y., Zhao, W., Chen, F., Liu, J., Antihypertensive effect of angiotensin-converting enzyme inhibitory peptide RVPSL on spontaneously hypertensive rats by regulating gene expression of the renin-angiotensin system. J. Agric. Food Chem. 2014, 62, 912-917.
24. Valdés, A., Simó, C., Ibáñez, C., García-Cañas, V., Chapter 5-Emerging RNA-Seq Applications in Food Science-Comprehensive Analytical Chemistry, Elsevier, Oxford 2014, pp. 107-128.
25. Wang, Z., Gerstein, M., Snyder, M., RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 2009, 10, 57-63.
26. Wang, C., Gong, B., Bushel, P. R., Mieg, J. T. et al., The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance. Nat. Biotech. 2014, 32, 926-932.
27. Kim, D., Pertea, G., Trapnell, C., Pimentel, H. et al., TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013, 14, R36.
28. Robinson, M. D., McCarthy, D. J., Smyth, G. K., edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010, 26, 139-140.
29. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 1995, 57, 289-300.
30. Liang, G., Malmuthuge, N., McFadden, T. B., Bao, H. et al., Potential regulatory role of microRNAs in the development of bovine gastrointestinal tract during early life. PLoS One 2014, 9, e92592.
31. Craddick, S. R., Elmer, P. J., Obarzanek, E., Vollmer, W. M., The DASH diet and blood pressure. Curr. Atheroscler. Rep. 2003, 5, 484-491.
32. Batchu, S. N., Chaudhary, K. R., Wiebe, G. J., Seubert, J. M., in: Watson, R. R., Preedy, V. R. (Eds.), Chapter 28-Bioactive Compounds in Heart Disease-Bioactive Food as Dietary Interventions for Cardiovascular Disease, Academic Press, San Diego 2013, pp. 431-442.
33. Fernández-Mar, M. I., Mateos, R., García-Parrilla, M. C., Puertas, B., Cantos-Villar, E., Bioactive compounds in wine: resveratrol, hydroxytyrosol and melatonin: a review. Food Chem. 2012, 130, 797-813.
34. Al-Shalmani, S., Suri, S., Hughes, D. A., Kroon, P. A. et al., Quercetin and its principal metabolites, but not myricetin, oppose lipopolysaccharide-induced hyporesponsiveness of the porcine isolated coronary artery. Br. J. Pharmacol. 2011, 162, 1485-1497.
35. Sudano, I., Spieker, L. E., Hermann, F., Flammer, A. et al., Protection of endothelial function: targets for nutritional and pharmacological interventions. J. Cardiovasc. Pharmacol. 2006, 47 (Suppl 2), S136-S150.
36. Schramm, D. D., German, J. B., Potential effects of flavonoids on the etiology of vascular disease. J. Nutr. Biochem. 1998, 9, 560-566.
37. Huntley, A. L., The health benefits of berry flavonoids for menopausal women: cardiovascular disease, cancer and cognition. Maturitas 2009, 63, 297-301.
38. Martinez-Maqueda, D., Miralles, B., Recio, I., Hernandez-Ledesma, B., Antihypertensive peptides from food proteins: a review. Food Funct. 2012, 3, 350-361.
39. Aleixandre, A., Miguel, M., Muguerza, B., Peptides with antihypertensive activity obtained from milk and egg proteins. Nutr. Hosp. 2008, 23, 313-318.
40. Cheung, I. W. Y., Nakayama, S., Hsu, M. N. K., Samaranayaka, A. G. P., Li-Chan, E. C. Y., Angiotensin-I converting enzyme inhibitory activity of hydrolysates from oat (Avena sativa) proteins by in silico and in vitro analyses. J. Agric. Food Chem. 2009, 57, 9234-9242.
41. Getek, M., Czech, N., Fizia, K., Bialek-Dratwa, A. et al., Nutrigenomics-bioactive dietary components. Postepy Hig. Med. Dosw. 2013, 67, 255-260.
42. Kivimäki, A. S., Ehlers, P. I., Siltari, A., Turpeinen, A. M. et al., Lingonberry, cranberry and blackcurrant juices affect mRNA expressions of inflammatory and atherothrombotic markers of SHR in a long-term treatment. J. Func. Foods 2012, 4, 496-503.
43. Bansode, R. R., Randolph, P., Hurley, S., Ahmedna, M., Evaluation of hypolipidemic effects of peanut skin-derived polyphenols in rats on Western-diet. Food Chem. 2012, 135, 1659-1666.
44. Salamon, H., Bruiners, N., Lakehal, K., Shi, L. et al., Cutting edge: vitamin D regulates lipid metabolism in Mycobacterium tuberculosis infection. J. Immunol. 2014, 193, 30-34.
45. Sales, N. M., Pelegrini, P. B., Goersch, M. C., Nutrigenomics: definitions and advances of this new science. J. Nutr. Metab. 2014, 2014, 202759.
46. Castro-Chaves, P., Cerqueira, R., Pintalhao, M., Leite-Moreira, A. F., New pathways of the renin-angiotensin system: the role of ACE2 in cardiovascular pathophysiology and therapy. Expert. Opin. Ther. Targets 2010, 14, 485-496.
47. Kuba, K., Imai, Y., Ohto-Nakanishi, T., Penninger, J. M., Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol. Ther. 2010, 128, 119-128.
48. Giannotti, G., Landmesser, U., Endothelial dysfunction as an early sign of atherosclerosis. Herz 2007, 32, 568-572.
49. Pober, J. S., Min, W., Bradley, J. R., Mechanisms of endothelial dysfunction, injury, and death. Annu. Rev. Pathol. 2009, 4, 71-95.
50. Mori, M., Kasa, S., Isozaki, Y., Kamori, T. et al., Improvement of the cellular quality of cryopreserved bovine blastocysts accompanied by enhancement of the ATP-binding cassette sub-family B member 1 expression. Reprod. Toxicol. 2013, 35, 17-24.
51. Ieiri, I., Takane, H., Otsubo, K., The MDR1 (ABCB1) gene polymorphism and its clinical implications. Clin. Pharmacokinet. 2004, 43, 553-576.
52. Jeannesson, E., Siest, G., Bastien, B., Albertini, L. et al., Association of ABCB1 gene polymorphisms with plasma lipid and apolipoprotein concentrations in the STANISLAS cohort. Clin. Chim. Acta 2009, 403, 198-202.
53. Cucuianu, M., Coca, M., Hancu, N., Reverse cholesterol transport and atherosclerosis. A mini review. Rom. J. Intern. Med. 2007, 45, 17-27.
54. Pennings, M., Meurs, I., Ye, D., Out, R. et al., Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development. FEBS Lett. 2006, 580, 5588-5596.
55. Wang, Q., Jin, Y. Z., Zhou, S. B., Wang, L. J. et al., ABCB1 C3435T polymorphism and the risk of ischemic heart disease: a meta-analysis. Genet. Test. Mol. Biomarkers 2014, 18, 636-45.
56. Keskitalo, J. E., Kurkinen, K. J., Neuvonen, M., Backman, J. T. et al., No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin. Br. J. Clin. Pharmacol. 2009, 68, 207-213.
57. Onnie, C. M., Fisher, S. A., Pattni, R., Sanderson, J. et al., Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis study. Inflamm. Bowel Dis. 2006, 12, 263-271.
58. Berx, G., Staes, K., van Hengel, J., Molemans, F. et al., Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 1995, 26, 281-289.
59. Lee, J. M., Dedhar, S., Kalluri, R., Thompson, E. W., The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 2006, 172, 973-981.
60. Armstrong, E. J., Bischoff, J., Heart valve development: endothelial cell signaling and differentiation. Circ. Res. 2004, 95, 459-470.
61. Zhang, S. M., Gao, L., Zhang, X. F., Zhang, R. et al., Interferon regulatory factor 8 modulates phenotypic switching of smooth muscle cells by regulating the activity of myocardin. Mol. Cell. Biol. 2014, 34, 400-414.
62. The Editors. Circulation research thematic synopsis: atherosclerosis. Circ. Res. 2012, 111, e123-e162.
63. Cizek, S. M., Bedri, S., Talusan, P., Silva, N. et al., Risk factors for atherosclerosis and the development of preatherosclerotic intimal hyperplasia. Cardiovasc. Pathol. 2007, 16, 344-350.